Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richetta

Showing results (211-220 of 233) with videos related to

Pageof 24
Sort By:
Dermatology Practical & Conceptual|November 14, 2025
Long-Term Persistence with Guselkumab: A 5-Year Multicenter Retrospective Study across 14 Dermatology Centers in ItalyBernardini Nicoletta, Caldarola Giacomo, Richetta Antonio Giovanni, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 InterfacesDelphine Lapaillerie, Cathy Charlier, Véronique Guyonnet-Dupérat, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Diverse Participant Recruitment for Infant Sequencing in the BabySeq ProjectMaya C Del Rosario, Sheyenne A Walmsley, Barbara W Harrison, et al.
BMC Medical Genomics|January 28, 2026
Designing inclusive newborn sequencing research: insights from parents in underrepresented communitiesMaya C Del Rosario, Sheyenne A Walmsley, Barbara W Harrison, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and VenereologyAlessia Paganelli, Andrea Michelerio, Maria C Collina, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Frontiers in Immunology|November 3, 2023
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infectionDéborah Lécuyer, Roberta Nardacci, Désirée Tannous, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Journal of Clinical Medicine|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus StatementMaria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Pageof 24

Showing results (211-220 of 233) with videos related to

Sort By:
Pageof 24
Dermatology Practical & Conceptual|November 14, 2025
Long-Term Persistence with Guselkumab: A 5-Year Multicenter Retrospective Study across 14 Dermatology Centers in ItalyBernardini Nicoletta, Caldarola Giacomo, Richetta Antonio Giovanni, et al.
Antimicrobial Agents and Chemotherapy|July 21, 2022
Selection of Bis-Indolyl Pyridines and Triphenylamines as New Inhibitors of SARS-CoV-2 Cellular Entry by Modulating the Spike Protein/ACE2 InterfacesDelphine Lapaillerie, Cathy Charlier, Véronique Guyonnet-Dupérat, et al.
Medrxiv : the Preprint Server for Health Sciences|October 17, 2024
Diverse Participant Recruitment for Infant Sequencing in the BabySeq ProjectMaya C Del Rosario, Sheyenne A Walmsley, Barbara W Harrison, et al.
BMC Medical Genomics|January 28, 2026
Designing inclusive newborn sequencing research: insights from parents in underrepresented communitiesMaya C Del Rosario, Sheyenne A Walmsley, Barbara W Harrison, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Clinical management of pigmented purpuric dermatoses: evidence from a survey among the Study Group on Cutaneous Vascular Diseases of the Italian Society of Dermatology and VenereologyAlessia Paganelli, Andrea Michelerio, Maria C Collina, et al.
Dermatology and Therapy|February 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE StudyEmanuele Trovato, Claudio Bonifati, Simone Ribero, et al.
Frontiers in Immunology|November 3, 2023
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infectionDéborah Lécuyer, Roberta Nardacci, Désirée Tannous, et al.
Journal of Clinical Medicine|May 28, 2022
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient WellbeingFrancesca Prignano, Alexandra M G Brunasso, Gabriella Fabbrocini, et al.
Journal of Clinical Medicine|May 27, 2023
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus StatementMaria Concetta Fargnoli, Federico Bardazzi, Luca Bianchi, et al.
Journal of Cutaneous Medicine and Surgery|March 17, 2026
Long-Term Outcomes of Secukinumab in Moderate-to-Severe Hidradenitis Suppurativa: A Multicentre Cohort StudyGianluca Avallone, Gabriele Roccuzzo, Luca Valtellini, et al.
Pageof 24